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1. Introduction 
The antibiotics distamycin A and actinomycin D 
interact with double-stranded DNA forming non- 
covalently bound complexes. This interaction is 
rather selective: distamycin forms complexes pre- 
ferentially with d(A/T) rich regions [ 11 whereas 
actinomycin binds d(G/C) rich regions [2] of DNA. 
This property has offered a possibility to use these 
antibiotics for effective and highly selective protec- 
tion of the cleavage sites recognized by restriction 
endonucleases [3,4]. The recognition site of endo 
R. HindIII [5] 
5’ AAGCTT 
3’TTCGAA 
may be protected by both actinomycin D and 
distamycin A as long as it contains TT and GC 
sequences favourable for interaction of distamycin 
and actinomycin with template DNA. It has been 
demonstrated [4] that different EcoRI recognition 
sites on lambda DNA may be effectively blocked by 
different antibiotic concentrations due to the peculi- 
arities of the environment of different recognition 
sites. In the present paper it is shown that certain 
endo R. Hind111 sites of phage lambda DNA may be 
effectively protected with actinomycin whereas some 
other sites are protected with distamycin. This allows 
us to obtain a set of larger overlapping fragments of 
DNA (hereafter we shall term them as distamycin and 
actinomycin protected fragments) and to establish 
the location of all Hind111 fragments on the physical 
map of phage lambda DNA. The data reported here 
and earlier [3,4] lead to a conclusion that the anti- 
North-Holland Publishing Company - Amsterdam 
biotics may be useful for DNA mapping and for 
obtaining new vector molecules. 
2. Materials and methods 
2.1. Bacteriophage DNA 
Lambda ~1857~7 DNA was obtained from purified 
phage particles by phenol extraction [6]. 
2.2. Restriction endonuclease and digestion 
Endo R. Hind111 was purified according to R. J. 
Robert’s unpublished procedure with insignificant 
modifications. The enzyme was free of non-specific 
nucleases. The standard incubation mixture contained 
10 mM Tris-HCl, pH 7.5, 10 mM MgCls, 10 mM 
mercaptoethanol, 0.5 pg of lambda DNA, l-2 ~1 of 
restriction endonuclease, distamycin A or actino- 
mycin D in 10 /.d volume. The reaction mixture was 
incubated for l-3 h at 37°C. The reaction was 
terminated by adding EDTA. The digested samples 
were heated for 5 min at 65°C and then rapidly 
cooled in ice to prevent interaction of the cohesive 
ends. 
2.3. Agarose gel electrophoresis 
The 0.5-I .O% agarose gels (Sigma) were used for 
separation of the DNA fragments. The gels were 
prepared according to Helling et al. [7] and electro- 
phoresis was carried out in a tube-type apparatus at 
2.0-4.0 V/cm for about 14-17 h. The gels were 
stained in electrophoresis buffer containing 0.5 I.cg/ml 
ethidium bromide. The DNA fragments were visua- 
lized by long wave ultraviolet light (C50 Transillumin- 
ator, Ultraviolet Product, San Gabriel, Calif.). The size 
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of actinomycin and distamycin protected fragments 
was calculated by their electrophoretic mobility. The 
lambda DNA fragments generated by endo R. Hind111 
were used as inside molecular weight standards 
according to the procedure described earlier [3]. 
2.4. Distamycin and actinomycin 
For the present experiments we have used dista- 
mycin A (Calbiochem) and actinomycin D (Reanal). 
The concentrations of the antibiotics in solution were 
calculated basing on their optical density. The molar 
absorption coefficient of distamycin A is 30 000 at 
302 nm [ 11, and that of actinomycin D is 24 000 at 
445 nm [2]. 
3. Results and discussion 
Endo R. Hind111 cleaves lambda phage DNA into 
seven fragments designated by letters A-G in the 
order of their decreasing size. These fragments were 
(1) 
a b u d e 
A -- 
-2A 
-3A 
B- 
c--_ 
,4A 
I)- 
previously ordered within the map of lambda genome 
[8,9] with the aid of lambda phage deletion mutants 
and by means of digestion of lambda DNA with both 
endo R. Hind111 and endo EcoRI. In this work the 
overlapping Hind111 fragments were obtained by use 
of actinomycin D and distamycin A. 
The addition of actinomycin produces partial 
protection of certain Hind111 recognition sites and 
appearance of actinomycin protected fragments 
(fig.l(I)). To determine more accurately the molecular 
weight of larger actinomycin fragments the eiectro- 
phoresis was carried out in a 0.5% agarose gel, and 
lambda DNA was added to the HindIII-digest as a 
marker (fig.l(II)). The effect of site protection depends 
on the antibiotic concentration. Figures l(1) and l(I1) 
show that fragments 1 A and 3A appear at low actino- 
mycin concentrations (0.3 X lo4 M) whereas higher 
actinomycin concentrations protect other Hind111 
sites giving rise to fragments 4A and 2A. Having deter- 
mined the molecular weights of actinomycin protected 
fragments (see table l), the order of their appearance 
a b c c’ 
A 
/ 
‘c r,DRA 
e.e ‘IA 
- 3A 
Fig.1. Electrophoretic pattern of lambda phage DNA digested with endo R. Hind111 in the presence of actinomycin. (I) Electro- 
phoresis carried out at 2.0 V/cm for 16 h; 1% agarose gel. Concentrations ofactinomycin D in reaction mixture (lOUa M): 
(a) none; (b) 0.3; (c) 0.5; (d) 0.7; (e) 1.0. (II). Electrophoresis carried out at 3V/cm for 14 hrs; 0.5% agarose gel. (a)-(c) the same 
as in I; (c’) the same as (c) plus lambda phage DNA added as a marker. 
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Table 1 
Molecular weight and composition of distamycin and actinomycin protected 
fragments of DNA (hc1857s7 DNA cleaved by endo R. HindIII) 
DNA fragments Mol. wt. x 10-6 
experimental 
Composition Mol. wt. 
x 1o-6 
calculated 
Actinomycin 
fragments (see 
tig.1) 
1A 
2A 
3A 
4A 
Distamycin 
fragments (see 
f-lg.2) 
15.70 * 0.55 A,F 15.88 
12.14 r 0.35 B,C,E,C 12.04 
7.66 * 0.20 B,E 7.56 
4.50 f 0.12 CC 4.48 
1D 16.35 + 0.50 B,C,D,E,F,C 16.15 
2D 9.35 + 0.30 B,E,F,C 9.17 
3D 9.00 * 0.28 B,E,F 8.82 
4D 7.15 * 0.20 CD 7.33 
5D 6.34 + 0.10 B,C 6.36 
and the order of disappearance of the original frag- 
ments we identified fragments 1 A and 3A as AF and 
EB, and fragments 4A and 2A as GC and EBGC, 
respectively. 
The electrophoretic patterns of endo R. Hind111 
fragments of lambda DNA obtained in the presence 
of distamycin A are given in fig.2. It is obvious that 
the increase of distamycin concentration has induced 
the disappearance of the original fragments as well as 
the formation of larger distamycin protected fragments 
of DNA. At relatively high concentrations of dista- 
mycin (> 1.5 X 10S4 M) the enzyme splits the phage 
lambda DNA into two fragments (see fig.2c,d). One of 
them is fragment A, and the other one is fragment 1D 
which can be identified by its molecular weight as a 
block of fragments FEBGCD (see table I), i.e. at 
this concentration distamycin protects all the endo 
Fig.2. Electrophoretic patterns of lambda DNA digested with 
endo R. Hind111 in the presence of different concentrations 
of distamycin (lob4 M): (a) 0.5; (b) 1.0; (c) 1.5; (d) 2.0; 
(e) no distamycin. Electrophoresis carried out at 2.5 V/cm 
for 17 h; 0.7% agarose gel. 
abode 
XDNA 
ZAn'D 
,- 3 
1-D 
93 
Volume 70, number 1 FEBS LETTERS November 1976 
R. Hind111 sites except site 1 which remains partially 
available for the enzyme. A considerable part of 
lambda DNA remains uncleaved at these distamycin 
concentrations. The decrease of distamycin concen- 
tration (0.75-1.0 X lo4 M) produces two additional 
fragments, 2D and 4D (fig.2b) that may be identified 
as FEBG and CD (see table 1). At moderate concen- 
tration of the antibiotic (0.5 X lo4 M) endo 
R. Hind111 produces a set of distamycin protected 
fragments (see fig.2a) which were identified by their 
molecular weights (see table 1). 
‘Thus, having selective affinity for particular 
sequences of double-stranded DNA, distamycin A and 
actinomycin D protect different Hind111 recognition 
sites in lambda DNA. This property of the antibiotics 
permits to obtain overlapping fragments of DNA and 
establish the order of Hind111 fragments in lambda 
DNA: 
AF 
FEB 
EB 
BG 
FEBG 
EBGC 
GC 
CD 
FEBGCD 
Actinomycin 
Distamycin 
Actinomycin 
Distamycin 
Distamycin 
Actinomycin 
Actinomycin 
Distamycin 
Distamycin 
AFEBGCD 
This result is in good agreement with the map 
built with the use of the deletion mutants [8,9] (see 
fig.3). 
The proposed method for DNA mapping is based 
on selective protection of the recognition sites of the 
restriction endonuclease with an antibiotic. Different 
affinity of the antibiotic for the sites of one and the 
same restriction endonuclease is, presumably, explained 
by a different environment of the sites. Since dista- 
mycin interacts preferentially with d(A/T)-rich regions 
and actinomycin with d(G/C)-rich regions of DNA we 
may expect that the sequences with strong affinity 
for distamycin have weaker affinity for mycin, and 
vice versa. Indeed, at moderate concentrations, actino- 
mycin protects completely site 1 and partially sites 3 
and 5, while distamycin protects sites 2,4,6, and 3. 
These data are schematically shown on fig.3. At rela- 
tively high concentration of distamycin 0 1.5 X 1 0e4 M) 
only site 1 is available for endo R. HindIII. This allows 
to split lambda DNA into two large fragments. 
Our iesults suggest hat distamycin A and actino- 
mycin D may be useful to obtain overlapping DNA 
fragments and to map DNA. 
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Fig.3. Hind111 sites protected with actinomycin and distamycin on lambda phage DNA. (a) Physical map of lambda phage DNA; 
(b) Hind111 cleavage map of lambda DNA [8,9]. The sites protected with moderate concentrations of the antibiotics are indicated 
with asterisks; the sites cleaved with the enzyme in the conditions are indicated with arrows. 
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